The Effectiveness of the Dosed Cream Acilact Duo in Patients with Bacterial Vaginosis

Ye.V. Tikhomirova, Vysakh Balan, Ye.V. Kruchinina, P. Balan, S. Orlova, Y. Titchenko, Ye.A. Levkovich, V. Yatsyuk
{"title":"The Effectiveness of the Dosed Cream Acilact Duo in Patients with Bacterial Vaginosis","authors":"Ye.V. Tikhomirova, Vysakh Balan, Ye.V. Kruchinina, P. Balan, S. Orlova, Y. Titchenko, Ye.A. Levkovich, V. Yatsyuk","doi":"10.33978/2307-3586-2023-19-7-6-12","DOIUrl":null,"url":null,"abstract":"Bacterial vaginosis is a clinical condition in which the normal vaginal microflora, predominantly lactobacilli, is replaced by other microorganisms, mainly anaerobes. The goal of treating bacterial vaginosis is to restore the normal microflora of the vagina, to delay the growth of microorganisms that are not characteristic of this vaginal microcenosis. The purpose of the study was to evaluate the effectiveness of various methods of combined two-stage treatment of bacterial vaginosis in women of reproductive age. Material and methods. The study included 50 patients aged 18 to 45 years (mean age 29.6 ± 4.5 years) with bacterial vaginosis. The first group consisted of 25 patients who received Clindamycin 2% cream for 7 days, dose vaginally at night. For the second stage of therapy in this 1 group, acidophilus bacteria + vitamin-mineral-protein-peptide complex Superlimfly (Acylact Duo) were used, suppository time per day at night intravaginally for 10 days. The second group consisted of 25 patients who received Clindacimin cream for 7 days, dose vaginally at night. For the second stage of therapy, a preparation containing a lyophilized culture of lactobacilli L. casei rhamnosus Doderleini was used, at least 1 × 108 CFU, capsule in the vagina at night for 14 days. Results. The effectiveness of BV therapy was 49% (n = 46). The duration of remission was 24.1 ± 2.1 days (n = 24) in the group of women receiving adjuvant therapy with Acilact Duo dosed cream, and 19.9 ± 2 3. days (n = 22) in the comparison group. In all patients, the average vaginal pH before therapy was 5.5 ± 0.4. In group1 participants, after therapy, the pH was 4.54 ± 0.143 , in group 2 patients, the average vaginal pH was 4.976 ± 0.241. Among the patients of both groups, vaginal dysbiosis of varying severity was detected before treatment (normocenosis was not detected). After therapy, in patients of group, normocenosis of the vagina was achieved in 88% (22/25), in participants of group 2, normocenosis was noted in 72% (18/25). At visit (in 45 days) in women of the group 1 84% (21/25), in the participants of the group 2 – normocenosis was noted in 64% (16/25). Conclusions. Acidophilic bacteria + vitamin-mineral-protein-peptide complex Superlymfly (in which dosed Acylact Duo) quickly restores the optimal acidity of the vagina (pH value) and promotes the growth of the number of beneficial lactobacilli, as a result of which it creates an optimal and natural microflora that prevents the appearance of dysbiosis in patients of reproductive age","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Effective Pharmacotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33978/2307-3586-2023-19-7-6-12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Bacterial vaginosis is a clinical condition in which the normal vaginal microflora, predominantly lactobacilli, is replaced by other microorganisms, mainly anaerobes. The goal of treating bacterial vaginosis is to restore the normal microflora of the vagina, to delay the growth of microorganisms that are not characteristic of this vaginal microcenosis. The purpose of the study was to evaluate the effectiveness of various methods of combined two-stage treatment of bacterial vaginosis in women of reproductive age. Material and methods. The study included 50 patients aged 18 to 45 years (mean age 29.6 ± 4.5 years) with bacterial vaginosis. The first group consisted of 25 patients who received Clindamycin 2% cream for 7 days, dose vaginally at night. For the second stage of therapy in this 1 group, acidophilus bacteria + vitamin-mineral-protein-peptide complex Superlimfly (Acylact Duo) were used, suppository time per day at night intravaginally for 10 days. The second group consisted of 25 patients who received Clindacimin cream for 7 days, dose vaginally at night. For the second stage of therapy, a preparation containing a lyophilized culture of lactobacilli L. casei rhamnosus Doderleini was used, at least 1 × 108 CFU, capsule in the vagina at night for 14 days. Results. The effectiveness of BV therapy was 49% (n = 46). The duration of remission was 24.1 ± 2.1 days (n = 24) in the group of women receiving adjuvant therapy with Acilact Duo dosed cream, and 19.9 ± 2 3. days (n = 22) in the comparison group. In all patients, the average vaginal pH before therapy was 5.5 ± 0.4. In group1 participants, after therapy, the pH was 4.54 ± 0.143 , in group 2 patients, the average vaginal pH was 4.976 ± 0.241. Among the patients of both groups, vaginal dysbiosis of varying severity was detected before treatment (normocenosis was not detected). After therapy, in patients of group, normocenosis of the vagina was achieved in 88% (22/25), in participants of group 2, normocenosis was noted in 72% (18/25). At visit (in 45 days) in women of the group 1 84% (21/25), in the participants of the group 2 – normocenosis was noted in 64% (16/25). Conclusions. Acidophilic bacteria + vitamin-mineral-protein-peptide complex Superlymfly (in which dosed Acylact Duo) quickly restores the optimal acidity of the vagina (pH value) and promotes the growth of the number of beneficial lactobacilli, as a result of which it creates an optimal and natural microflora that prevents the appearance of dysbiosis in patients of reproductive age
剂量性乳膏Acilact Duo治疗细菌性阴道病的疗效观察
细菌性阴道病是一种临床状况,其中正常的阴道微生物群,主要是乳酸菌,被其他微生物,主要是厌氧菌所取代。治疗细菌性阴道病的目的是恢复阴道的正常菌群,以延缓微生物的生长,不是这种阴道微囊病的特征。本研究的目的是评价两期联合治疗育龄妇女细菌性阴道病的各种方法的有效性。材料和方法。本研究纳入50例18 ~ 45岁(平均29.6±4.5岁)细菌性阴道病患者。第一组25例患者接受2%克林霉素乳膏7天,夜间阴道给药。第二期治疗采用嗜酸杆菌+维生素-矿物质-蛋白-肽复合物Superlimfly (Acylact Duo),每天夜间经阴道灌栓一次,持续10天。第二组25例患者连续7天服用克林西敏乳膏,夜间经阴道给药。在第二阶段治疗中,使用含有干酪乳杆菌鼠李糖杜氏乳杆菌冻干培养物的制剂,至少1 × 108 CFU胶囊,每晚阴道内服用14天。结果。BV治疗的有效率为49% (n = 46)。接受Acilact Duo软膏辅助治疗组缓解时间为24.1±2.1天(n = 24),而接受Acilact Duo软膏辅助治疗组缓解时间为19.9±2.3天。(n = 22)。所有患者治疗前阴道pH平均值为5.5±0.4。治疗后,组1患者阴道pH值为4.54±0.143,组2患者阴道pH值平均为4.976±0.241。两组患者均在治疗前发现不同程度的阴道生态失调(未发现正常增生)。治疗后,1组患者中88%(22/25)的患者阴道恢复正常,2组患者中72%(18/25)的患者阴道恢复正常。在就诊时(45天内),组中84%(21/25)的女性,在2组参与者中-正常生育的比例为64%(16/25)。结论。嗜酸菌+维生素-矿物质-蛋白-肽复合物Superlymfly(其中添加Acylact Duo)迅速恢复阴道的最佳酸度(pH值),促进有益乳酸菌数量的增长,因此它创造了一个最佳和自然的微生物群,防止育龄患者出现生态失调
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信